VIDEO | 31:50
Learn about these four innovative companies at the 2025 MSK Direct Benefits Leaders’ Summit, who are influencing the future of early cancer detection through personalization and emerging technologies, featuring:
- Peter B. Bach, MD, MAPP, Chief Medical Officer, Delfi Diagnostics
- Kara Egan, Co-founder, Chief Executive Officer, Teal Health
- Kathryn Rooks, MBA, Chief Marketing Officer, SkinIO
- Rebecca Miksad, MD, MMS, MPH, Chief Medical Officer, Color Health Inc.